Spyre Therapeutics


Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.

Employees

11-50

Links


Org chart

Cameron Turtle
Chief Executive Officer
Collapse
Brian Connolly
Chief Technical Officer
Heidy King - Jones
Chief Legal Officer And Corporate Secretary
Scott Burrows
Chief Financial Officer
Andrew Spencer
Svp, Preclinical Research And Development
Deanna Nguyen
Svp, Clinical Development
Janet Gunzner - Toste
Svp, Operations
Joshua Friedman
Svp, Clinical Development
James Myers
Vp, Quality And Compliance
Melissa Cooper
Svp, People